Recombinant Human CTLA-4 protein (hFc Tag)
ED50
5-22 ng/mL
Species
Human
Purity
>95 %, SDS-PAGE
GeneID
1493
Accession
P16410
验证数据展示
Technical Specifications
Purity | >95 %, SDS-PAGE |
Endotoxin Level | <1.0 EU/μg protein, LAL method |
Biological Activity |
Immobilized Human CD86 (Myc tag, His tag) at 0.5 μg/mL (100 μL/well) can bind Human CTLA-4 (hFc tag) with a linear range of 5-22 ng/mL. |
Source | HEK293-derived Human CTLA-4 protein Lys36-Asp161 (Accession# P16410) with a human IgG1 Fc tag at the C-terminus. |
Predicted Molecular Mass | 39.5 kDa |
SDS-PAGE | 42-50 kDa, reducing (R) conditions |
Formulation | Lyophilized from sterile PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
CTLA-4, also known as CD152, belonging to the immunoglobulin superfamily, is primarily found on activated T cells and regulatory T cells (Tregs). CTLA-4 is closely related to the T-cell costimulatory CD28, and both molecules bind to B7-1 and B7-2 on antigen-presenting cells. CTLA-4 acts as a negative regulatory molecule of T-cell responses. Besides the full-length transmembrane form, CTLA-4 also exists in a truncated soluble form (sCTLA-4).
References:
1. Brunet JF, et al. (1987) Nature. 328(6127):267-70. 2. Harper K, et al. (1991) J Immunol. 147(3):1037-44. 3. McCoy KD, et al. (1999) Immunol Cell Biol. 77(1):1-10. 4. Oaks MK, et al. (2000) Cell Immunol. 201(2):144-53.